A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group

MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2

(2011) Chang Zheng et al.   MEDICAL ONCOLOGY

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

(2011) Fulya Yaman Agaoglu et al.   TUMOR BIOLOGY

Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer

(2011) Robert Mahn et al.   UROLOGY

Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

(2010) Helen M. Heneghan et al.   ANNALS OF SURGERY

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer

(2010) Kah Hoong Chang et al.   BMC CANCER

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

(2010) Rui Liu et al.   EUROPEAN JOURNAL OF CANCER

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease

(2010) H. M. Heneghan et al.   ONCOLOGIST

Increase of microRNAmiR-31level in plasma could be a potential marker of oral cancer

(2010) C-J Liu et al.   ORAL DISEASES

Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells

(2010) Lukas Vrba et al.   PLoS One

Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

(2010) Hai-Liang Zhang et al.   PROSTATE

The implementation of screening for prostate cancer

(2010) P J van Leeuwen et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

(2009) E K O Ng et al.   GUT

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

(2009) Annika Schaefer et al.   INTERNATIONAL JOURNAL OF CANCER

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

(2009) Zhaohui Huang et al.   INTERNATIONAL JOURNAL OF CANCER

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray

(2009) Michael J. Lodes et al.   PLoS One

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

(2008) Charles H. Lawrie et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA profile analysis of human prostate cancers

(2008) A W Tong et al.   CANCER GENE THERAPY

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

(2008) T.-S. Wong et al.   CLINICAL CANCER RESEARCH

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer

(2008) Robyn L. Prueitt et al.   PROSTATE